File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Review on the current use of antipsychotic drugs in children and adolescents

TitleReview on the current use of antipsychotic drugs in children and adolescents
Authors
KeywordsAripiprazole
Atypical antipsychotic agent
Chlorpromazine
Clozapine
Haloperidol
Issue Date2011
PublisherB M J Publishing Group.
Citation
Archives of Disease in Childhood. Education and Practice Edition, 2011, v. 96 n. 5, p. 192-196 How to Cite?
AbstractAntipsychotic (neuroleptic) drugs are used in the treatment of various psychiatric disorders in children and adolescents. There is a lack of information about the efficacy and safety of antipsychotics in young people. Much of the information available is extrapolated from adult studies; in particular, little is known about the long-term effects of these drugs on the development of the central nervous system. Over the last two decades, typical antipsychotics have largely been replaced by atypical antipsychotics. With this increase in use of atypical antipsychotic drugs, there has been growing concern about the appropriate use of these drugs and the fact that they appear to be associated with metabolic abnormalities such as weight gain, diabetes and related cardiovascular effects. This paper provides a review of current practice and evidence based use of antipsychotic drugs in children.
Persistent Identifierhttp://hdl.handle.net/10722/171431
ISSN
2015 Impact Factor: 1.333
2015 SCImago Journal Rankings: 0.575
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorAlmandil, NBen_US
dc.contributor.authorWong, ICKen_US
dc.date.accessioned2012-10-30T06:14:08Z-
dc.date.available2012-10-30T06:14:08Z-
dc.date.issued2011en_US
dc.identifier.citationArchives of Disease in Childhood. Education and Practice Edition, 2011, v. 96 n. 5, p. 192-196en_US
dc.identifier.issn1743-0585en_US
dc.identifier.urihttp://hdl.handle.net/10722/171431-
dc.description.abstractAntipsychotic (neuroleptic) drugs are used in the treatment of various psychiatric disorders in children and adolescents. There is a lack of information about the efficacy and safety of antipsychotics in young people. Much of the information available is extrapolated from adult studies; in particular, little is known about the long-term effects of these drugs on the development of the central nervous system. Over the last two decades, typical antipsychotics have largely been replaced by atypical antipsychotics. With this increase in use of atypical antipsychotic drugs, there has been growing concern about the appropriate use of these drugs and the fact that they appear to be associated with metabolic abnormalities such as weight gain, diabetes and related cardiovascular effects. This paper provides a review of current practice and evidence based use of antipsychotic drugs in children.en_US
dc.languageengen_US
dc.publisherB M J Publishing Group.en_US
dc.relation.ispartofArchives of Disease in Childhood. Education and Practice Editionen_US
dc.rightsArchives of Disease in Childhood. Education and Practice Edition. Copyright © B M J Publishing Group.-
dc.subjectAripiprazole-
dc.subjectAtypical antipsychotic agent-
dc.subjectChlorpromazine-
dc.subjectClozapine-
dc.subjectHaloperidol-
dc.subject.meshPediatrics - Methodsen_US
dc.subject.meshAripiprazoleen_US
dc.subject.meshAtypical antipsychotic agenten_US
dc.subject.meshChlorpromazineen_US
dc.subject.meshClozapineen_US
dc.subject.meshHaloperidolen_US
dc.titleReview on the current use of antipsychotic drugs in children and adolescentsen_US
dc.typeArticleen_US
dc.identifier.emailWong, ICK: wongick@hku.hken_US
dc.identifier.authorityWong, ICK=rp01480en_US
dc.description.naturelink_to_OA_fulltexten_US
dc.identifier.doi10.1136/archdischild-2011-300054en_US
dc.identifier.pmid21771730-
dc.identifier.scopuseid_2-s2.0-80052866904en_US
dc.identifier.hkuros207211-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-80052866904&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume96en_US
dc.identifier.issue5en_US
dc.identifier.spage192en_US
dc.identifier.epage196en_US
dc.identifier.isiWOS:000294853100005-
dc.publisher.placeUnited Kingdomen_US
dc.identifier.scopusauthoridWong, ICK=7102513915en_US
dc.identifier.scopusauthoridAlmandil, NB=43061058200en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats